Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys

…, R Leighty, M Yao, M Bernardo, L Ileva… - Journal of the …, 2008 - academic.oup.com
Background Patients with Birt-Hogg-Dubé (BHD) syndrome harbor germline mutations in
the BHD tumor suppressor gene that are associated with an increased risk for kidney cancer. …

Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors

JM Weiss, LC Davies, M Karwan, L Ileva… - The Journal of …, 2018 - Am Soc Clin Investig
Control of cellular metabolism is critical for efficient cell function, although little is known
about the interplay between cell subset–specific metabolites in situ, especially in the tumor …

Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin

SM Saud, MR Young, YL Jones-Hall, L Ileva… - Cancer research, 2013 - AACR
Abstract Analysis of the Polyp Prevention Trial showed an association between an
isorhamnetin-rich diet and a reduced risk of advanced adenoma recurrence; however, the …

Pazopanib Reveals a Role for Tumor Cell B-Raf in the Prevention of HER2+ Breast Cancer Brain Metastasis

B Gril, D Palmieri, Y Qian, DD Smart, L Ileva… - Clinical Cancer …, 2011 - AACR
Purpose: Brain metastases of breast cancer contribute significantly to patient morbidity and
mortality. We have tested pazopanib, a recently approved antiangiogenic drug that targets …

TFE3 Xp11. 2 translocation renal cell carcinoma mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease

…, Y Satou, N Morris, BO Karim, L Ileva… - Molecular Cancer …, 2019 - AACR
Key findings from studies with this preclinical mouse model of TFE3-RCC underscore the
potential for RET as a therapeutic target for treatment of patients with TFE3-RCC, and suggest …

A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives

…, H Xu, CAS Regino, M Bernardo, L Ileva… - Bioconjugate …, 2009 - ACS Publications
In this paper, we report a new method to prepare and characterize a contrast agent based
on a fourth-generation (G4) polyamidoamine (PAMAM) dendrimer conjugated to the …

A tumor-targeted nanodelivery system to improve early MRI detection of cancer

…, M Freedman, A Vladar, S Fricke, L Ileva… - Molecular …, 2006 - journals.sagepub.com
The development of improvements in magnetic resonance imaging (MRI) that would enhance
sensitivity, leading to earlier detection of cancer and visualization of metastatic disease, is …

Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography

MR Young, LV Ileva, M Bernardo, LA Riffle, YL Jones… - Neoplasia, 2009 - Elsevier
Early detection of precancerous tissue has significantly improved survival of most cancers
including colorectal cancer (CRC). Animal models designed to study the early stages of …

Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI

…, J VanMeter, E Shapiro, HN Dai, M Casimiro, L Ileva… - Cell Cycle, 2006 - Taylor & Francis
The development of effective cancer therapies has been hampered, in part, by the inability
to non-invasively follow tumor progression from the initial cancerous lesion through to …

In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models

…, CD Chien, T Newell, K Johnson, L Ileva… - The …, 2006 - Wiley Online Library
BACKGROUND Mouse prostate cancer modeling presents unique obstacles to the study of
spontaneous tumor initiation and progression due to the anatomical location of the tissue. …